Robert A. Wermers MD

Robert A. Wermers, M.D., studies clinical and epidemiologic aspects of metabolic bone disease. This includes an analysis of five decades of the epidemiology of primary hyperparathyroidism in Rochester, Minnesota. He has also reviewed the epidemiologic aspects of thiazide-associated hyperparathyroidism and Paget's disease of bone in Rochester.

Dr. Wermers is also interested in clinic research in the field of metabolic bone disease, with multiple projects in several different areas, including evaluating the effect of parathyroidectomy on depression and bone mineral density in primary hyperparathyroidism, clinical features of adult hypophosphatasia, decision aids in the treatment of osteoporosis, combination therapy for the treatment of osteoporosis, and fluoride-related bone disease.